NasdaqHealth CareServices-Medical LaboratoriesTAIPEI CITY, Taiwan

YD Bio Limited YDES

Ask your AI

Estimated market cap $345.45M70.79M shares, shares as of Dec 31, 2025CIK 2011674

Insider trades, 12 mo

3 buys · 0 sells

$128.5K bought, open market

Congress trades, 24 mo

—

No disclosed trades

13F holders, Q3 2026

4 added · 2 trimmed

13F holders

…

Lobbying, 12 mo

—

No lobbying filings

Federal contracts, 12 mo

—

None matched

Ask your AI:

Latest 10-Q

What changed in YD Bio Limited's latest quarterly report, compared with the one before.

We have not read a recent 10-Q for this company yet.

Insider trades

3 in 12 mo

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

No open-market insider trades reported since Sep 14, 2026. Insiders have two business days to file.

Recent insider trades

Ethan Shen PhD CEO, Director	Sep 14 Form 4 ↗	Buy	+$48.9K 12,700 sh @ $3.85	+28.3%
Ethan Shen PhD CEO, Director	Sep 9 Form 4 ↗	Buy	+$12.2K 3,100 sh @ $3.93	+25.4%
Ethan Shen PhD CEO, Director	Sep 4 Form 4 ↗	Buy	+$67.4K 18,378 sh @ $3.67	+39.9%

All YDES insider trades →Planned sales (Form 144): see notices

Insider trades

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

Loading…

13F holders

396,747 shares

9 funds report YDES. Values checked against market prices.

Funds own 0.4% of shares (Q2 2026)

12 funds hold the stock.

Q3 2026: 0.6% · 5,560 of ~8,900 funds reported so far

Q3 20250.2%
Q4 20250.2%
Q1 20260.2%
Q2 20260.4%
Q3 2026 (so far)0.6%

Q3 2026. 1 new, 4 added to, 2 trimmed, 5 exited since Q2 2026.

Top 13F holders
#
1	Cerity Partners LLC 13F ↗	107,406	$797.0K	+231.4%
2	Garrett Wealth Advisory Group, LLC 13F ↗	84,630	$628.0K	unchanged
3	Jane Street Group, LLC 13F ↗	78,322	$581.1K	+265.6%
4	Geode Capital Management, LLC 13F ↗	44,942	$333.5K	-28.3%
5	Cypress Capital Management LLC (WY) 13F ↗	29,970	$222.4K	-11.0%
6	UBS Group AG 13F ↗	29,086	$215.8K	+134.9%
7	HRT Financial LP 13F ↗	21,837	$162.0K	n/a
8	Morgan Stanley 13F ↗	549	$4,074	+243.1%
9	JPMorgan Chase & Co 13F ↗	5	$38	New

One of these funds reports its values in thousands of dollars; its figures are shown in dollars.

Download CSV Every fund that holds YDES, not only these ten. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

13F holders

Funds that report this stock, checked against market prices.

Loading…

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

No recent congressional trades for this company.

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

Loading…

Lobbying

What YD Bio Limited and its lobbying firms report each quarter.

No recent lobbying filings for this company.

Lobbying

What YD Bio Limited and its lobbying firms report each quarter.

Loading…

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Funds holding the stock

Shares they report

Funds holding the stock by quarter

Q3 2025	10	—	175,508	$3.4M
Q4 2025	10	0	141,580	$1.7M
Q1 2026	8	-2	159,520	$1.2M
Q2 2026	12	+4	282,592	$635.6K
Q3 2026	9	-3	396,747	$2.9M

Each point is a quarter-end, from Q3 2025 to Q3 2026. A fund's 13F lists its long positions in US-listed securities as of the last day of the quarter and arrives up to 45 days later, so each point shows holdings at quarter-end, not on the day they were reported.

Common shares only; options and bonds are left out. When a fund amends a report, the amended version is the one counted.

The history follows the company's current CUSIP number (G98301107). If the company's shares were ever re-issued under a different CUSIP, the quarters before the change are not part of this series, so the first point (Q3 2025) can be later than the stock's first appearance in 13F reports.

Share counts are adjusted for stock splits; none took place between these quarters. Values are in dollars as reported at the time and are not adjusted.

A quarter appears once our daily update has built its summary. If a summary cannot be built, older reports are kept and the chart shows the quarters it has until the next update repairs it.

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Loading…

More filings and data

Each opens the table.

Ownership stakes2 in 12 mo 8-K eventsNone in 90 days PatentsNone on record Short interestFINRA · updated Oct 15 Planned insider salesNone in 12 mo Executive payNone on record Wikipedia attentionNone on record SEC enforcementNone on record IPO history1 registration Ownership stakes…8-K events…Patents…Short interest…Planned insider sales…Executive pay…Wikipedia attention…SEC enforcement…

About the company

The basics from the company’s SEC registration.

Legal name: YD Bio Ltd
Address: 12F., NO. 3, XINGNAN ST., NANGANG DIST., TAIPEI CITY, Taiwan 115001
Phone: 619-500-7747
Fiscal year ends: Dec 31
Filer category: Non-accelerated filer, smaller reporting company, emerging growth company
Incorporated in: Cayman Islands
Listed as: YDES (Nasdaq), YDESW (Nasdaq)
Former names: True Velocity, Inc./DE (until 2024)
SEC filings: All filings on SEC EDGAR ↗

About the company

The basics from the company’s SEC registration.

Loading…

$4.88−$0.32 (−6.06%) Nov 13 close

1M3M1Y

Oct 13, 2026Low $4.24 · High $7.18Nov 13, 2026

Aug 13, 2026Low $2.51 · High $8.11Nov 13, 2026

Nov 13, 2025Low $1.90 · High $15.42Nov 13, 2026

Congress purchase Congress sale Insider sale over $1M

Adjusted for stock splits; not for dividends. Where prices come from.

Live chart

Intraday and historical prices from TradingView. Quotes may be delayed.

Loading chart…

Information, not investment advice. Company matching is automatic; check the source before relying on one row.